Janet E. Brown

Janet Brown is a UK oncologist and researcher specializing in bone health in cancer patients, with particular focus on bisphosphonate therapy for breast cancer bone metastases and adjuvant settings. She has contributed to AZURE and other studies evaluating zoledronate in early breast cancer and helped define which patient populations derive adjuvant benefit from bone-targeting agents. Her research addresses renal toxicity of bisphosphonates, optimal dosing intervals, and biomarkers of bone resorption as monitoring tools. She leads educational programs on bone health in oncology.